EP Patent

EP3206705A4 — Stable injectable composition of bivalirudin and process for its preparation

Assigned to Piramal Enterprises Ltd · Expires 2018-05-23 · 8y expired

What this patent protects

Patent listed against Angiomax.

Drugs covered by this patent

Patent Metadata

Patent number
EP3206705A4
Jurisdiction
EP
Classification
—
Expires
2018-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Piramal Enterprises Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.